(no title)
olejorgenb | 4 months ago
"Phase III for Clinical Efficacy Trial – beginning in 2025
Our product MAG200 has successfully completed Phase I/II of a clinical trials on the use of allogeneic (donor) off-the-shelf stem cell therapy for OA. The pivotal Phase III trial is planned to commence in 2025."
No comments yet.